295 related articles for article (PubMed ID: 9001242)
1. Constitutive activation of Epstein-Barr virus (EBV) nuclear antigen 1 gene transcription by IRF1 and IRF2 during restricted EBV latency.
Schaefer BC; Paulson E; Strominger JL; Speck SH
Mol Cell Biol; 1997 Feb; 17(2):873-86. PubMed ID: 9001242
[TBL] [Abstract][Full Text] [Related]
2. Interferon regulatory factor 2 represses the Epstein-Barr virus BamHI Q latency promoter in type III latency.
Zhang L; Pagano JS
Mol Cell Biol; 1999 Apr; 19(4):3216-23. PubMed ID: 10082588
[TBL] [Abstract][Full Text] [Related]
3. Interferon-independent and -induced regulation of Epstein-Barr virus EBNA-1 gene transcription in Burkitt lymphoma.
Nonkwelo C; Ruf IK; Sample J
J Virol; 1997 Sep; 71(9):6887-97. PubMed ID: 9261415
[TBL] [Abstract][Full Text] [Related]
4. Interferon regulatory factor 7 is induced by Epstein-Barr virus latent membrane protein 1.
Zhang L; Pagano JS
J Virol; 2000 Feb; 74(3):1061-8. PubMed ID: 10627515
[TBL] [Abstract][Full Text] [Related]
5. The Epstein-Barr virus latency BamHI-Q promoter is positively regulated by STATs and Zta interference with JAK/STAT activation leads to loss of BamHI-Q promoter activity.
Chen H; Lee JM; Wang Y; Huang DP; Ambinder RF; Hayward SD
Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9339-44. PubMed ID: 10430944
[TBL] [Abstract][Full Text] [Related]
6. Transcription of the Epstein-Barr virus nuclear antigen 1 (EBNA1) gene occurs before induction of the BCR2 (Cp) EBNA gene promoter during the initial stages of infection in B cells.
Schlager S; Speck SH; Woisetschläger M
J Virol; 1996 Jun; 70(6):3561-70. PubMed ID: 8648690
[TBL] [Abstract][Full Text] [Related]
7. IRF-7, a new interferon regulatory factor associated with Epstein-Barr virus latency.
Zhang L; Pagano JS
Mol Cell Biol; 1997 Oct; 17(10):5748-57. PubMed ID: 9315633
[TBL] [Abstract][Full Text] [Related]
8. The interferon-stimulable response elements of two human genes detect overlapping sets of transcription factors.
Parrington J; Rogers NC; Gewert DR; Pine R; Veals SA; Levy DE; Stark GR; Kerr IM
Eur J Biochem; 1993 Jun; 214(3):617-26. PubMed ID: 7686487
[TBL] [Abstract][Full Text] [Related]
9. Host-cell-determined methylation of specific Epstein-Barr virus promoters regulates the choice between distinct viral latency programs.
Schaefer BC; Strominger JL; Speck SH
Mol Cell Biol; 1997 Jan; 17(1):364-77. PubMed ID: 8972217
[TBL] [Abstract][Full Text] [Related]
10. CTCF prevents the epigenetic drift of EBV latency promoter Qp.
Tempera I; Wiedmer A; Dheekollu J; Lieberman PM
PLoS Pathog; 2010 Aug; 6(8):e1001048. PubMed ID: 20730088
[TBL] [Abstract][Full Text] [Related]
11. A simple reverse transcriptase PCR assay to distinguish EBNA1 gene transcripts associated with type I and II latency from those arising during induction of the viral lytic cycle.
Schaefer BC; Strominger JL; Speck SH
J Virol; 1996 Nov; 70(11):8204-8. PubMed ID: 8892954
[TBL] [Abstract][Full Text] [Related]
12. The Epstein-Barr virus major latent promoter Qp is constitutively active, hypomethylated, and methylation sensitive.
Tao Q; Robertson KD; Manns A; Hildesheim A; Ambinder RF
J Virol; 1998 Sep; 72(9):7075-83. PubMed ID: 9696800
[TBL] [Abstract][Full Text] [Related]
13. Heat shock factor 1 upregulates transcription of Epstein-Barr Virus nuclear antigen 1 by binding to a heat shock element within the BamHI-Q promoter.
Wang FW; Wu XR; Liu WJ; Liao YJ; Lin S; Zong YS; Zeng MS; Zeng YX; Mai SJ; Xie D
Virology; 2011 Dec; 421(2):184-91. PubMed ID: 22018489
[TBL] [Abstract][Full Text] [Related]
14. Methylation of the EBV genome and establishment of restricted latency in low-passage EBV-infected 293 epithelial cells.
Paulson EJ; Fingeroth JD; Yates JL; Speck SH
Virology; 2002 Jul; 299(1):109-21. PubMed ID: 12167346
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel element involved in regulation of the lytic switch BZLF1 gene promoter of Epstein-Barr virus.
Kraus RJ; Mirocha SJ; Stephany HM; Puchalski JR; Mertz JE
J Virol; 2001 Jan; 75(2):867-77. PubMed ID: 11134300
[TBL] [Abstract][Full Text] [Related]
16. PU box-binding transcription factors and a POU domain protein cooperate in the Epstein-Barr virus (EBV) nuclear antigen 2-induced transactivation of the EBV latent membrane protein 1 promoter.
Sjöblom A; Jansson A; Yang W; Laín S; Nilsson T; Rymo L
J Gen Virol; 1995 Nov; 76 ( Pt 11)():2679-92. PubMed ID: 7595375
[TBL] [Abstract][Full Text] [Related]
17. High-resolution analysis of CpG methylation and in vivo protein-DNA interactions at the alternative Epstein-Barr virus latency promoters Qp and Cp in the nasopharyngeal carcinoma cell line C666-1.
Bakos A; Banati F; Koroknai A; Takacs M; Salamon D; Minarovits-Kormuta S; Schwarzmann F; Wolf H; Niller HH; Minarovits J
Virus Genes; 2007 Oct; 35(2):195-202. PubMed ID: 17510783
[TBL] [Abstract][Full Text] [Related]
18. Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines.
Schaefer BC; Strominger JL; Speck SH
Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10565-9. PubMed ID: 7479841
[TBL] [Abstract][Full Text] [Related]
19. Autorepression of Epstein-Barr virus nuclear antigen 1 expression by inhibition of pre-mRNA processing.
Yoshioka M; Crum MM; Sample JT
J Virol; 2008 Feb; 82(4):1679-87. PubMed ID: 18077719
[TBL] [Abstract][Full Text] [Related]
20. Repression of Epstein-Barr virus EBNA-1 gene transcription by pRb during restricted latency.
Ruf IK; Sample J
J Virol; 1999 Oct; 73(10):7943-51. PubMed ID: 10482541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]